These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35609303)

  • 1. Discovery of a Novel Series of Imipridone Compounds as
    Huang J; Zhang J; Luo B; Qiao W; Qiu Z; Song R; Dai Z; Sui J; Xu X; Ruan S; Li C; Luo Y; Yang T
    J Med Chem; 2022 Jun; 65(11):7629-7655. PubMed ID: 35609303
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity.
    Xiang X; Dai Z; Luo B; Zhao N; Liu S; Sui J; Huang J; Zhou Y; Gu J; Zhang J; Yang T; Bao R; Luo Y
    J Med Chem; 2024 Apr; 67(8):6769-6792. PubMed ID: 38620134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Novel Series of
    Zhang J; Qiu Z; Liu S; Huang J; Luo B; Sui J; Dai Z; Xiang X; Yang T; Luo Y
    J Med Chem; 2024 Feb; 67(4):2812-2836. PubMed ID: 38329974
    [No Abstract]   [Full Text] [Related]  

  • 4. Discovery of novel indolin-2-one compounds as potent inhibitors of HsClpP for cancer treatment.
    Song R; Yang Y; Huang J; Qiao W; Luo B; Ju Y; Yang T; Luo Y
    Bioorg Chem; 2021 May; 110():104820. PubMed ID: 33773224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma.
    Liu S; Sui J; Luo B; Zhang J; Xiang X; Yang T; Luo Y; Liu J
    J Med Chem; 2024 Jul; 67(13):10622-10642. PubMed ID: 38905539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
    Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives.
    Ren B; Liu RC; Ji K; Tang JJ; Gao JM
    Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and anti-tumor activity of novel benzothiophenonaphthalimide derivatives targeting mitochondrial DNA (mtDNA) G-quadruplex.
    Huang Q; Wang X; Chen A; Zhang H; Yu Q; Shen C; Awadasseid A; Zhao X; Xiong X; Wu Y; Zhang W
    Biochem Pharmacol; 2022 Jul; 201():115062. PubMed ID: 35504316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Antiproliferative Activity of Novel Imipridone-Ferrocene Hybrids with Triazole and Alkyne Linkers.
    Czuczi T; Murányi J; Bárány P; Móra I; Borbély A; Csala M; Csámpai A
    Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel β-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway.
    Wang Y; Wu C; Zhang Q; Shan Y; Gu W; Wang S
    Bioorg Chem; 2019 Mar; 84():468-477. PubMed ID: 30576910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway.
    Wei G; Sun J; Hou Z; Luan W; Wang S; Cui S; Cheng M; Liu Y
    Eur J Med Chem; 2018 Sep; 157():759-772. PubMed ID: 30142612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity.
    Cheng C; Yun F; Ullah S; Yuan Q
    Eur J Med Chem; 2020 Mar; 189():112073. PubMed ID: 31991336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel diosgenin-amino acid-benzoic acid mustard trihybrids exert antitumor effects via cell cycle arrest and apoptosis.
    Wang W; Li C; Chen Z; Zhang J; Ma L; Tian Y; Ma Y; Guo L; Wang X; Ye J; Wang X
    J Steroid Biochem Mol Biol; 2022 Feb; 216():106038. PubMed ID: 34861390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity.
    Yun F; Cheng C; Ullah S; He J; Zahi MR; Yuan Q
    Eur J Med Chem; 2019 Aug; 176():195-207. PubMed ID: 31103900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.
    Wagner J; Kline CL; Ralff MD; Lev A; Lulla A; Zhou L; Olson GL; Nallaganchu BR; Benes CH; Allen JE; Prabhu VV; Stogniew M; Oster W; El-Deiry WS
    Cell Cycle; 2017 Oct; 16(19):1790-1799. PubMed ID: 28489985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.
    Zhang J; Luo B; Sui J; Qiu Z; Huang J; Yang T; Luo Y
    Biochem Pharmacol; 2022 Oct; 204():115232. PubMed ID: 36030831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
    Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
    Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
    Hiriyan J; Shivarudraiah P; Gavara G; Annamalai P; Natesan S; Sambasivam G; Sukumaran SK
    Anticancer Res; 2015 Jan; 35(1):229-37. PubMed ID: 25550555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.
    Prabhu VV; Talekar MK; Lulla AR; Kline CLB; Zhou L; Hall J; Van den Heuvel APJ; Dicker DT; Babar J; Grupp SA; Garnett MJ; McDermott U; Benes CH; Pu JJ; Claxton DF; Khan N; Oster W; Allen JE; El-Deiry WS
    Cell Cycle; 2018; 17(4):468-478. PubMed ID: 29157092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.
    Jiang BE; Hu J; Liu H; Liu Z; Wen Y; Liu M; Zhang HK; Pang X; Yu LF
    Eur J Med Chem; 2022 Jan; 227():113893. PubMed ID: 34656899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.